Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

SCYNEXIS, Inc. (SCYX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

SCYNEXIS, Inc. (SCYX), most recent 12 months reported: revenue $19.21M, net loss $10.23M. Latest balance sheet on file: liquid cash $54.08M. From SEC filings. Others in Pharmaceutical Preparations: Janux Therapeutics, Inc. · PRELUDE THERAPEUTICS INC · CASI PHARMACEUTICALS, INC. · Sol-Gel Technologies Ltd. · Celularity Inc. · CytomX Therapeutics, Inc. · uniQure N.V. · EVOFEM BIOSCIENCES, INC.

Stock screener

Watchlist